β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis

被引：0
|
作者：
Uta Drebber
Martin Madeja
Margarete Odenthal
Inga Wedemeyer
Stefan P. Mönig
Jan Brabender
Elfriede Bollschweiler
Arnulf H. Hölscher
Paul M. Schneider
Hans P. Dienes
Daniel Vallböhmer
机构：
[1] University Hospital Cologne,Institute of Pathology
[2] University Hospital Cologne,Department of General, Visceral and Cancer Surgery
[3] University Hospital Zurich,Department of Visceral and Transplantation Surgery
来源：
International Journal of Colorectal Disease | 2011年 / 26卷
关键词：
Rectal cancer; Neoadjuvant therapy; Response prediction; Prognosis; β-catenin; Her2/neu;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis
    Drebber, Uta
    Madeja, Martin
    Odenthal, Margarete
    Wedemeyer, Inga
    Moenig, Stefan P.
    Brabender, Jan
    Bollschweiler, Elfriede
    Hoelscher, Arnulf H.
    Schneider, Paul M.
    Dienes, Hans P.
    Vallboehmer, Daniel
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (09) : 1127 - 1134
  • [2] Survivin Expression in Gastric Cancer: Association With Histomorphological Response to Neoadjuvant Therapy and Prognosis
    Vallboehmer, D.
    Drebber, U.
    Schneider, P. M.
    Baldus, S.
    Bollschweiler, E.
    Brabender, J.
    Warnecke-Eberz, U.
    Moenig, S.
    Hoelscher, A. H.
    Metzger, R.
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (07) : 409 - 413
  • [3] Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer
    Taucher, S
    Rudas, M
    Mader, RM
    Gnant, M
    Sporn, E
    Dubsky, P
    Roka, S
    Bachleitner, T
    Fitzal, F
    Kandioler, D
    Wenzel, C
    Steger, GG
    Mittlböck, M
    Jakesz, R
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (03) : 207 - 213
  • [4] HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer
    Kwon, Mi Jung
    Soh, Jae Seung
    Lim, Sang-Woo
    Kang, Ho Suk
    Lim, Hyun
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (05) : 910 - 917
  • [5] Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: Association with response to neoadjuvant therapy and prognosis
    Meng, Xiangjiao
    Wang, Renben
    Huang, Zhaoqin
    Zhang, Jianbo
    Feng, Rui
    Xu, Xiaoqing
    Zhu, Kunli
    Dou, Xue
    Chen, Dong
    Yu, Jinming
    CANCER SCIENCE, 2014, 105 (07) : 818 - 824
  • [6] HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy
    Junker, K
    Stachetzki, U
    Rademacher, D
    Linder, A
    Macha, HN
    Heinecke, A
    Müller, KM
    Thomas, M
    LUNG CANCER, 2005, 48 (01) : 59 - 67
  • [7] Expression of HER2 in colorectal cancer does not correlate with prognosis
    Kruszewski, Wieslaw Janusz
    Rzepko, Robert
    Ciesielski, Maciej
    Szefel, Jaroslaw
    Zielinski, Jacek
    Szajewski, Mariusz
    Jasinski, Wojciech
    Kawecki, Krzysztof
    Wojtacki, Janusz
    DISEASE MARKERS, 2010, 29 (05) : 207 - 212
  • [8] Strategies to target HER2/neu overexpression for cancer therapy
    Chen, JS
    Lan, K
    Hung, MC
    DRUG RESISTANCE UPDATES, 2003, 6 (03) : 129 - 136
  • [9] Comparison of serum HER2/neu with immunohistochemical HER2/neu expression for the prediction of biochemical progression in metastatic prostate cancer
    Tambo, Mitsuhiro
    Higashihara, Eiji
    Terado, Yuichi
    Nutahara, Kikuo
    Okegawa, Takatsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (04) : 369 - 374
  • [10] HER2/neu expression in Venezuelan patients with locally advanced breast cancer
    Morales, Luisa
    Reigosa, Aldo
    Caleiras, Eduardo
    Mora, Richard
    Marrero, Nuria
    Payares, Eliecer
    Molina, Karla
    Sucre, Luis
    INVESTIGACION CLINICA, 2008, 49 (01): : 69 - 78
12345